Boehringer Ingelheim Pharmaceuticals, Inc. has recalled approximately 1,380 bottles of Catapres .2 (clonidine hydrochloride, USP) 0.2mg tablets, a prescription medication used to treat high blood pressure. The recall was initiated because routine stability testing showed the tablets failed dissolution specifications, meaning the drug may not dissolve properly in the body as intended. This defect could potentially lead to inconsistent absorption of the medication, affecting its efficacy in managing blood pressure. Consumers who have these specific 100-count bottles should consult their healthcare provider or pharmacist.
If the medication fails to dissolve properly, the body may not receive the correct dose of clonidine hydrochloride at the right time. This can lead to ineffective control of high blood pressure, potentially causing a patient's blood pressure to rise unexpectedly.
Contact your healthcare provider or pharmacist for guidance. Return any unused product to the pharmacy for a refund
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.